Angle Health announced a $200.0M Series C as part of a larger $600 million equity financing at a $2.7 billion valuation that also includes a $400 million tender offer, representing a follow-on Series C round expected to close later this month. The round was led by Vitruvian Partners with participation from new investor Town Hall Ventures and existing investors Blumberg Capital, Portage Ventures, PruVen Capital, and Y Combinator. The provided excerpt did not disclose specific operating metrics such as clients, revenue, pipeline or employee count, nor detailed planned use of funds or expansion plans.